...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Could it be
3
Oct 27, 2023 10:54AM

I premised some similar thoughts about a month ago as to the possibility of the partners getting into a bidding war for control of zenith so they could supply(or withhold) their competitors zenith supplies for other indications. 

5
Oct 27, 2023 12:17PM
5
Oct 27, 2023 02:59PM
Share
New Message
Please login to post a reply